Dr. Prema Abraham, MD

Dr. Abraham practices at Black Hills Regional Eye Surgery Center in Rapid City, South Dakota.

Dr. Abraham's NPI, 1063492940, was assigned on January 18, 2006. Dr. Abraham graduated from University of Arkansas College of Medicine in 1989. Dr. Abraham holds South Dakota license 3996.

Dr. Abraham's primary practice is Black Hills Regional Eye Surgery Center, at 2800 Third Street, Rapid City, SD 57701. The practice phone is (605) 341-4100.

Dr. Abraham's primary practice is Black Hills Regional Eye Surgery Center in Rapid City, South Dakota. Dr. Abraham is also affiliated with Monument Health Rapid City Hospital. Dmand AI also links Dr. Abraham to 1 more medical group, named with a free account. Dr. Abraham's employer is on file too: a surgery center (asc).

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Abraham practices, 2 sites in all. Vendor and product names are available with a free account.

Retina specialist is Dr. Abraham's primary specialty in the NPI Registry, under taxonomy code 207WX0107X. Dr. Abraham is licensed in South Dakota.

CMS data shows 2,559,288 Medicare services from Dr. Abraham across 30 procedure codes in 2024, for 1,792 Medicare patients. Medicare paid $11,139,904 for them.

CMS counts 1,792 Medicare patients who saw Dr. Abraham in 2024. The largest group is 65 to 74, with 681 patients. 74% of them have high blood pressure, and 66% have high cholesterol. 9% are also on Medicaid. Their average risk score is 1.39, where 1.00 is the Medicare average.

Across all payers, Dmand AI patient panel data puts Dr. Abraham's median patient age at 77, with 63% women.

In 2024, Dr. Abraham wrote 931 Medicare Part D claims for 298 patients. 55% of them were for generic drugs. CMS names the drug for 877 of them, across 9 drugs with 11 or more claims each, at $24,506 in total drug cost. In 2023, CMS named 682 claims across 9 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 80 out of 100 for Dr. Abraham for performance year 2024, reported as part of a group. Dr. Abraham accepts Medicare assignment, so Medicare's approved amount is taken as full payment.

Dmand AI links 7 papers to Dr. Abraham, published from 2013 to 2022. 2020 was the busiest year, with 2. The most frequent topics are Angiogenesis Inhibitors, Intravitreal Injections and Macular Degeneration. Dr. Abraham's most frequent co-authors are Clement K. Chan, MD, Maziar Lalezary, MD and Steven G. Lin, MD.

Dmand AI links Dr. Abraham to 3 clinical trials. Conditions studied include Edema, Macular Degeneration and Wet Macular Degeneration. Open Payments lists research payments to Dr. Abraham that name 1 trial.

CMS Open Payments shows 142 general payments to Dr. Abraham from 21 drug and device companies from 2016 to 2025. Food and beverage make up the largest share, 42% of the total. US Retina LLC paid the most, $2,892. It also lists 5 research payments totaling $21,890 from 2016 to 2023, naming 1 clinical trial.

Dr. Abraham graduated from University of Arkansas College of Medicine in 1989.